kabutan

DAIKEN MEDICAL, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 25%

Fri Jan 30, 2026 4:00 pm JST Earnings

7775 DAIKEN MEDICAL CO.,LTD. 【J-GAAP】

Earnings Report

DAIKEN MEDICAL CO.,LTD. <7775> [TSE Std] announced its financial results after the market closed on January 30th (16:00). The ordinary profit (non-consolidated) for the cumulative third quarter of the fiscal year ending March 2026 (April to December) decreased 15.2% from the same period last year to 1.11 billion yen.

However, the full-year forecast for ordinary profit has been revised upward 25.0%, from the previous forecast of 1.00 billion yen to 1.25 billion yen (compared to 1.51 billion yen in the previous period), and the declining rate is expected to decrease from 33.8% to 17.2%.

Based on the full-year plan announced by the company after the upward revision, our estimate of the ordinary profit for the October to March period (second half) has been revised upward 76.7%, from the previous forecast of 0.32 billion yen to 0.57 billion yen (compared to 0.67 billion yen in the same period of the previous year), and the declining rate is expected to decrease from 51.6% to 14.5%.

In the most recent three-month period, from October to December (3Q), the ordinary profit decreased to 0.44 billion yen, a 7.9% decrease compared to the same period last year. The operating profit margin decreased from 17.4% in the same period last year to 15.6%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2023 7,406 1,237 1,242 888 30.9 85.7 Jan 31, 2024 J-GAAP
Apr - Dec, 2024 7,665 1,315 1,315 957 33.3 87.1 Jan 31, 2025 J-GAAP
Apr - Dec, 2025 7,880 1,115 1,115 840 29.3 89.2 Jan 30, 2026 J-GAAP
YoY +2.8% -15.2% -15.2% -12.2% -12.2%

Guidance Update

Second Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2025 Prev 5,443 334 326 189 6.6 11 Oct 31, 2025 J-GAAP
Oct - Mar, 2025 New 5,143 574 576 369 12.8 11 Jan 30, 2026 J-GAAP
Revision Rate -5.5% +71.9% +76.7% +95.2% +95.1%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2026 Prev 10,500 1,010 1,000 700 24.4 20 May 15, 2025 J-GAAP
Mar, 2026 New 10,200 1,250 1,250 880 30.6 20 Jan 30, 2026 J-GAAP
Revision Rate -2.9% +23.8% +25.0% +25.7% +25.7%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 5,037 676 674 489 17.0 14 May 15, 2025 J-GAAP
Oct - Mar, 2025 Guidance 5,143 574 576 369 12.8 11 Jan 30, 2026 J-GAAP
YoY +2.1% -15.1% -14.5% -24.5% -24.6%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 9,750 1,442 1,450 988 34.4 21 May 15, 2024 J-GAAP
Mar, 2025 9,951 1,512 1,510 1,097 38.2 23 May 15, 2025 J-GAAP
Mar, 2026 Guidance 10,200 1,250 1,250 880 30.6 20 Jan 30, 2026 J-GAAP
YoY +2.5% -17.3% -17.2% -19.8% -19.8%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 2,751 479 479 349 12.2 17.4 Jan 31, 2025 J-GAAP
Jan - Mar, 2025 2,286 197 195 140 4.9 8.6 May 15, 2025 J-GAAP
Apr - Jun, 2025 2,497 281 282 215 7.5 11.3 Jul 31, 2025 J-GAAP
Jul - Sep, 2025 2,560 395 392 296 10.3 15.4 Oct 31, 2025 J-GAAP
Oct - Dec, 2025 2,823 439 441 329 11.5 15.6 Jan 30, 2026 J-GAAP
YoY +2.6% -8.4% -7.9% -5.7% -5.7%

Related Articles